| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.670 | 33.067 | 40.716 | 50.328 | 52.517 | 62.322 | 58.318 | 69.446 | 82.668 |
| Total Income - EUR | - | 7.670 | 33.067 | 40.716 | 50.329 | 52.518 | 62.325 | 58.322 | 69.449 | 82.671 |
| Total Expenses - EUR | - | 3.304 | 19.931 | 28.606 | 32.367 | 37.507 | 41.426 | 45.616 | 45.355 | 59.437 |
| Gross Profit/Loss - EUR | - | 4.366 | 13.136 | 12.110 | 17.962 | 15.011 | 20.899 | 12.706 | 24.094 | 23.234 |
| Net Profit/Loss - EUR | - | 4.291 | 12.806 | 11.703 | 17.459 | 14.486 | 20.276 | 12.123 | 23.399 | 20.754 |
| Employees | - | 1 | 0 | 0 | 3 | 3 | 3 | 0 | 3 | 3 |
Check the financial reports for the company - Derzis-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 1.766 | 2.138 | 1.653 | 1.788 |
| Current Assets | - | 4.966 | 13.875 | 25.357 | 20.928 | 20.431 | 23.457 | 16.820 | 38.202 | 23.880 |
| Inventories | - | 0 | 185 | 182 | 178 | 175 | 569 | 571 | 569 | 1.007 |
| Receivables | - | 0 | -408 | 1.575 | 3.387 | 2.337 | 1.772 | 1.088 | 5.383 | 1.470 |
| Cash | - | 4.966 | 14.099 | 23.600 | 17.362 | 17.919 | 21.115 | 15.161 | 32.250 | 21.404 |
| Shareholders Funds | - | 4.336 | 12.858 | 11.754 | 17.509 | 14.536 | 20.324 | 12.172 | 35.534 | 20.802 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 630 | 1.017 | 13.603 | 3.419 | 5.895 | 4.899 | 6.786 | 4.321 | 4.866 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Derzis-Med Srl